Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FBLG
#3765
FibroBiologics, Inc. Common Stock
0.3
3
+17.86%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+17.86%
Monthly Change
-8.33%
6 month change
-45.90%
Year Change
-72.73%
Previous Close
0.2
8
Open
0.3
3
Bid
Ask
Low
0.3
3
High
0.3
3
Volume
3
Markets
US Stock Market
Healthcare
FBLG
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2023
2024
2025
TTM
Cash from operating activities
6.4 M
11.9 M
16.39 M
16.39 M
Cash from investing activities
495 K
184 K
262 K
262 K
Cash from financing activities
13.79 M
16.91 M
7.57 M
7.57 M
Free cash flow
5.91 M
11.72 M
16.13 M
16.13 M
News
H.C. Wainwright cuts FibroBiologics stock price target to $4
FibroBiologics shareholders approve reverse stock split and warrant share issuances
FibroBiologics gets Nasdaq extension to meet listing rules
FibroBiologics to begin diabetic foot ulcer clinical trial in Q1 2026
FibroBiologics reports positive results for disc degeneration therapy
FibroBiologics receives Nasdaq delisting notice, requests hearing to appeal
FibroBiologics stock maintains Buy rating at H.C. Wainwright on psoriasis IND filing
FibroBiologics files IND application for psoriasis treatment
Fibrobiologics stock rises after FDA filing for psoriasis treatment
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/23/25 - TipRanks.com
FibroBiologics closes $1.7 million registered direct offering
FibroBiologics raises $1.7 million in registered direct offering